Man Group
RCUS icon

Man Group’s Arcus Biosciences RCUS Stock Holding History

Man Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Buy
+80,866
New +$1.75M ﹤0.01% 1628
2025
Q4 		– Sell
-75,486
Closed -$1.03M – 2431
2025
Q3 		$1.03M Sell
75,486
-1,433
-2% -$14.9K ﹤0.01% 1661
2025
Q2 		$626K Sell
76,919
-25,739
-25% -$220K ﹤0.01% 1764
2025
Q1 		$806K Buy
102,658
+90,080
+716% +$1.04M ﹤0.01% 1637
2024
Q4 		$187K Sell
12,578
-23,362
-65% -$382K ﹤0.01% 1880
2024
Q3 		$550K Buy
+35,940
New +$567K ﹤0.01% 1645
2024
Q1 		– Sell
-16,108
Closed -$308K – 2253
2023
Q4 		$308K Buy
+16,108
New +$257K ﹤0.01% 1812
2023
Q1 		– Sell
-54,099
Closed -$1.03M – 1337
2022
Q4 		$1.12M Buy
+54,099
New +$1.49M ﹤0.01% 1286
2022
Q2 		– Sell
-8,403
Closed -$265K – 2354
2022
Q1 		$265K Sell
8,403
-10,700
-56% -$359K ﹤0.01% 1811
2021
Q4 		$773K Sell
19,103
-2,849
-13% -$111K ﹤0.01% 1402
2021
Q3 		$765K Sell
21,952
-8,430
-28% -$262K ﹤0.01% 1424
2021
Q2 		$834K Sell
30,382
-6,094
-17% -$174K ﹤0.01% 1425
2021
Q1 		$1.02M Buy
36,476
+21,488
+143% +$748K ﹤0.01% 1284
2020
Q4 		$389K Buy
+14,988
New +$363K ﹤0.01% 1603

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Man Group's RCUS Position: Q1 2026 in Review

Man Group opened a new position in Arcus Biosciences (RCUS) in Q1 2026: 80,866 shares worth $1.75M. The stake represents ﹤0.01% of the portfolio and ranks #1628 among its holdings. This is a return to the name: Man Group previously reported a position in RCUS as recently as Q3 2025.

Man Group first reported a position in RCUS in Q4 2020 and has held it in 14 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Man Group held 80,866 shares of Arcus Biosciences worth $1.75M as of Q1 2026.
  • Arcus Biosciences was a new Man Group position in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1628 holding.
  • Man Group first reported a position in Arcus Biosciences in Q4 2020 and has held it in 14 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.